In acute myeloid leukaemia (AML), nucleophosmin-1 (NPM1) mutations create a nuclear export signal (NES) motif and disrupt tryptophans at NPM1 C-terminus, leading to nucleophosmin accumulation in leukaemic cell cytoplasm. We investigated how nucleophosmin NES motifs (two physiological and one created by the mutation) regulate traffic and interaction of mutated NPM1, NPM1wt and p14ARF. Nucleophosmin export into cytoplasm was maximum when the protein contained all three NES motifs, as naturally occurs in NPM1-mutated AML. The two physiological NES motifs mediated NPM1 homo/heterodimerization, influencing subcellular distribution of NPM1wt, mutated NPM1 and p14ARF in a 'dose-dependent tug of war' fashion. In transfected cells, excess doses of m...
Nucleophosmin (NPM) exon-12 mutations occur in 50% to 60% of adult acute myeloid leukemia (AML) with...
Mutations of the gene for nucleophosmin (NPM1) are the most frequent genetic aberration in patients ...
Nucleophosmin (NPM) exon-12 mutations occur in 50% to 60% of adult acute myeloid leukemia (AML) with...
Abstract We recently identified aberrant cytoplasmic expression of nucleophosmin (NPM) as the immun...
Nucleophosmin (NPM) is a nucleocytoplasmic shuttling protein, normally enriched in nucleoli, that pe...
Nucleophosmin (NPM) is a nucleus-cytoplasmic shuttling protein that is implicated in centrosome dupl...
Nucleophosmin (NPM1) is a highly conserved nucleo-cytoplasmic shuttling protein that shows a restric...
Acute myeloid leukemia (AML), the most common acute leukemia in adults, increases exponentially with...
Nucleophosmin (NPM1) is a nucleocytoplasmic shuttling protein, predominantly located in the nucleolu...
Nucleophosmin (NPM1) is a nucleocytoplasmic shuttling protein, predominantly located in the nucleolu...
Nucleophosmin (NPM1) is an abundant phospho-protein that plays a key role in ribosome biogenesis. NP...
Nucleophosmin (NPM) exon-12 mutations occur in 50% to 60% of adult acute myeloid leukemia (AML) with...
Nucleophosmin (NPM) is a nucleolar phosphoprotein implicated in the regulation of multiple cellular ...
The role exerted by the nucleus in the regulation of proteostasis in both health and disease is reco...
Nucleophosmin (NPM1) mutations in acute myeloid leukemia (AML) affect exon 12, but also sporadically...
Nucleophosmin (NPM) exon-12 mutations occur in 50% to 60% of adult acute myeloid leukemia (AML) with...
Mutations of the gene for nucleophosmin (NPM1) are the most frequent genetic aberration in patients ...
Nucleophosmin (NPM) exon-12 mutations occur in 50% to 60% of adult acute myeloid leukemia (AML) with...
Abstract We recently identified aberrant cytoplasmic expression of nucleophosmin (NPM) as the immun...
Nucleophosmin (NPM) is a nucleocytoplasmic shuttling protein, normally enriched in nucleoli, that pe...
Nucleophosmin (NPM) is a nucleus-cytoplasmic shuttling protein that is implicated in centrosome dupl...
Nucleophosmin (NPM1) is a highly conserved nucleo-cytoplasmic shuttling protein that shows a restric...
Acute myeloid leukemia (AML), the most common acute leukemia in adults, increases exponentially with...
Nucleophosmin (NPM1) is a nucleocytoplasmic shuttling protein, predominantly located in the nucleolu...
Nucleophosmin (NPM1) is a nucleocytoplasmic shuttling protein, predominantly located in the nucleolu...
Nucleophosmin (NPM1) is an abundant phospho-protein that plays a key role in ribosome biogenesis. NP...
Nucleophosmin (NPM) exon-12 mutations occur in 50% to 60% of adult acute myeloid leukemia (AML) with...
Nucleophosmin (NPM) is a nucleolar phosphoprotein implicated in the regulation of multiple cellular ...
The role exerted by the nucleus in the regulation of proteostasis in both health and disease is reco...
Nucleophosmin (NPM1) mutations in acute myeloid leukemia (AML) affect exon 12, but also sporadically...
Nucleophosmin (NPM) exon-12 mutations occur in 50% to 60% of adult acute myeloid leukemia (AML) with...
Mutations of the gene for nucleophosmin (NPM1) are the most frequent genetic aberration in patients ...
Nucleophosmin (NPM) exon-12 mutations occur in 50% to 60% of adult acute myeloid leukemia (AML) with...